Background and Aim: Carbapenem-resistant Acinetobacter baumannii (CRAB) is becoming
a global threat especially to hospitalized patients. We aimed to address the magnitude of …

Aims The present study was conducted to investigate the mechanism of carbapenem
resistance and the molecular epidemiology of carbapenem‐resistant Acinetobacter …

Acinetobacter baumannii is a nosocomial pathogen increasingly affecting the critically ill
patients and represents a major public health challenge. Carbapenem-resistant A …

Objectives The rise of carbapenem resistance in Acinetobacter baumannii represents a
challenge for the therapeutic management of infections. The present study aimed to …

CARBAPENEM resistant Acinetobacter baumannii (CRAB) now leads the WHO's critical
priority list of nosocomial pathogens worldwide. Carbapenem Hydrolysing Class D β …

Background: A. baumannii has now emerged as a leading cause of hospital and community-
acquired infections. Multidrug resistant A. baumannii has been increasingly reported …

The emergence of carbapenem-resistant Acinetobacter baumannii (CRAB) has now
become a global sentinel event. CRAB infections often instigate severe clinical …

Background The worldwide emergence and clonal spread of carbapenem-resistant
Acinetobacter baumannii (CRAB) is of great concern. The aim of this nationwide study was …

Of great concern is the increased frequency of carbapenem-resistant Acinetobacter
baumannii (CRAB) causing healthcare-associated infections. Different classes of β …

The molecular epidemiology and mechanisms of resistance of carbapenem-resistant
Acinetobacter baumannii (CRAB) were determined in hospitals in the states of the …